Davita Austell is a medicare approved dialysis facility center in Austell, Georgia and it has 12 dialysis stations. It is located in Cobb county at 3642 Marathon Circle, Austell, GA, 30106. You can reach out to the office of Davita Austell at (770) 439-4170. This dialysis clinic is managed and/or owned by Davita. Davita Austell has the following ownership type - Profit. It was first certified by medicare in February, 2010. The medicare id for this facility is 112825 and it accepts patients under medicare ESRD program.
| Name | Davita Austell |
|---|---|
| Location | 3642 Marathon Circle, Austell, Georgia |
| No. of Dialysis Stations | 12 |
| Medicare ID | 112825 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 3642 Marathon Circle, Austell, Georgia, 30106 | |
| (770) 439-4170 | |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
| NPI Number | 1427293943 |
| Organization Name | Austell Renal Center |
| Doing Business As | Isd Renal Inc |
| Address | 3642 Marathon Cir Austell, Georgia, 30106 |
| Phone Number | (770) 439-4170 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 23 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 13 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 46 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 330 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita Austell with elevated calcium levels.
| Patients with hypercalcemia | 47 |
| Hypercalcemia patient months | 331 |
| Patients with Serumphosphor | 49 |
| Patients with Serumphosphor less than 3.5 mg/dL | 14 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 15 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 52 |
| Patient months included in arterial venous fistula and catheter summaries | 311 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 11 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 45 |
| Hospitalization Rate in facility | 166.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 330.2 |
| Hospitalization Rate: Lower Confidence Limit | 87.7 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita Austell were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 13.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 28 |
| Readmission Rate: Lower Confidence Limit | 4.6 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita Austell get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.64 (As Expected) |
| SIR: Upper Confidence Limit | 3.97 |
| SIR: Lower Confidence Limit | .52 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita Austell's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 37 |
| Transfusion Rate in facility | 46.2 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 149.9 |
| Transfusion Rate: Lower Confidence Limit | 16.4 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita Austell lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 169 |
| Mortality Rate in facility | 24.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 37.2 |
| Mortality Rate: Lower Confidence Limit | 15.1 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago
FMC Dialysis Services South Cobb Location: 1886 Stallion Parkway, Austell, Georgia, 30106 Phone: (770) 944-3237 |
Colonial Springs Dialysis Location: 2840 East West Connector, Austell, Georgia, 30106 Phone: (770) 222-2236 |
Bio-Medical Applications Of Georgia, Inc. Location: 3602 Marathon Circle, Austell, Georgia, 30106 Phone: (770) 222-0253 |
News Archive
Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin. As an added benefit, the Soft & Shield Hand Sanitizer and Moisturizer forms an invisible protective barrier that covers the outer layer of the skin to protect for up to four hours against harmful germs and bacteria.
Computer-designed, 3D-printed models are emerging as a useful new tool for planning and carrying out cosmetic plastic surgery of the nose, reports a paper in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
› Verified 1 days ago